Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -31.59% | 61.87% | -280.69% | 74.61% | -35.31% |
| Total Depreciation and Amortization | -- | -- | -100.00% | 56.44% | 3.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -200.00% | 193.22% | -186.76% |
| Change in Net Operating Assets | -8.68% | -59.44% | 2,503.85% | -105.53% | 107.73% |
| Cash from Operations | -179.31% | -4.40% | 213.79% | 150.00% | 54.69% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 1,384.21% | 26.92% | -157.78% | -87.97% | 1,868.42% |
| Total Debt Repaid | -156.52% | -- | -- | -- | -314.63% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 175.00% | -255.56% | -156.25% | 166.67% | -129.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.45% | -69.86% | 19.67% | 158.10% | -400.00% |